Announcement

Collapse
No announcement yet.

Research Articles Abstract - 2010 Issues Archive

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • #16
    Re: Research Articles Abstracts - April 17, 2010

    what's the best way to keep updated here ?

    currently I'm doing :
    http://www.hubmed.org
    then "influenza"
    then "hide extracts" or "show extracts" depending on how much time I want to spend..

    I noticed that sometimes hubmed is not as actual a pubmed


    or:
    http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed
    influenza
    Results: 1 to 20 of 55049
    Display Settings
    *summary/text *100 *recently added


    best would be (IMO) just the headlines , no authors, no journal name,
    one line per clickable headline
    and then store the whole list for keyword-search

    the same could be done with all the abstracts included

    is it being done ? is it allowed (copyright) ?
    I'm interested in expert panflu damage estimates
    my current links: http://bit.ly/hFI7H ILI-charts: http://bit.ly/CcRgT

    Comment


    • #17
      Re: Research Articles Abstracts - April 17, 2010

      HubMed seems a nice tools.

      My lists are based upon a weekly newsletter dispatched by a review.

      However, since this service is sponsored by a drug company I cannot disclose the name in adherence of FluTrackers.com policy.

      Other contributors can add their suggests for a better coverage of these topics.

      Comment


      • #18
        Re: Research Articles Abstracts - April 17, 2010

        last 200, no links yet

        Code:
        Isolation and molecular characterization of a H5N1 virus isolated from a Junglecrow (Corvus macrohynchos) in India. [164]
        Experimental modeling of viral diseases of the locomotor system. [165]
        [A histopathological study on Influenza A H1N1 infection in humans.] [166]
        Update: influenza activity - United States, August 30, 2009-March 27, 2010, andcomposition of the 2010-11 influenza vaccine. [167]
        Zinc Intake and Resistance to H1N1 Influenza. [168]
        [Characteristics of hepatitis and influenza antivirals: update 2009.] [169]
        Risk factors for detection of bronchial casts, most frequently seen in endemicH9N2 avian influenza infection, in poultry flocks in Iran. [170]
        A randomized controlled trial of low-dose recombinant human interferonsalpha-2b nasal spray to prevent acute viral respiratory infections in militaryrecruits. [171]
        Long-term immunogenicity of influenza vaccine among the elderly: Risk factorsfor poor immune response and persistence. [172]
        The emergence of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virusamongst hospitalised immunocompromised patients in Scotland, November-December,2009. [173]
        Association of D222G substitution in haemagglutinin of 2009 pandemic influenzaA (H1N1) with severe disease. [174]
        Changes in receiving preventive care services among US adults with diabetes,1997-2007. [175]
        Identification of Hits as Matrix-2 Protein Inhibitors through the FocusedScreening of a Small Primary Amine Library. [176]
        Cardiac tamponade and heart failure due to myopericarditis as a presentation ofinfection with the pandemic H1N1 2009 influenza A virus. [177]
        Epidemiologic Study of Human Influenza Infection in Korea from 1999 to 2007:Origin and Evolution of A/Fujian/411/2002-like strains. [179]
        Characterization of H5N2 influenza viruses isolated in South Korea and theirinfluence on the emergence of a novel H9N2 influenza virus. [181]
        Evolution of highly pathogenic avian H5N1 influenza viruses and the emergenceof dominant variants. [183]
        In vitro assessment of attachment pattern and replication efficiency of H5N1influenza A viruses with altered receptor specificity. [185]
        Myocarditis associated with 2009 influenza A (H1N1) virus in children. [187]
        Clinical features of H1N1 2009 infection in critically ill immunocompromisedpatients. [189]
        The essentiality of alpha-2-macroglobulin in human salivary innate immunityagainst new H1N1 swine origin influenza A virus. [191]
        An outbreak of H7N6 low pathogenic avian influenza in quails in Japan. [193]
        Isolation of influenza A viruses from pigs in Ibadan, Nigeria. [195]
        Standardisation of a new model of H9N2/Escherichia coli challenge in broilersin the Lebanon. [197]
        Influenza and cardiovascular disease: does swine-origin, 2009 H1N1 flu virusrepresent a risk factor, an acute trigger, or both? [198]
        Susceptibility of two species of wild terrestrial birds to infection with ahighly pathogenic avian influenza virus of H5N1 subtype. [200]
        Evaluation of different serological tests for the detection of antibodiesagainst highly pathogenic avian influenza in experimentally infected ostriches(Struthio camelus). [202]
        Sequence and phylogenetic analysis of the haemagglutinin genes of H9N2 avianinfluenza viruses isolated from commercial chickens in Iran. [204]
        CD28 and IL-4: two heavyweights controlling the balance between immunity andinflammation. [206]
        Pandemic influenza: antiviral preparedness and health care workers. [208]
        Which health care workers were most affected during the spring 2009 H1N1pandemic? [210]
        Heterosubtypic neutralizing antibodies are produced by individuals immunizedwith a seasonal influenza vaccine. [212]
        2009 influenza A(H1N1) seroconversion rates and risk factors among distinctadult cohorts in Singapore. [214]
        A Computational Analysis of the Antigenic Properties of Haemagglutinin inInfluenza A H3N2. [216]
        Reporting bias in medical research - a narrative review. [218]
        [Characterization of human coronavirus 229E infection among patients withrespiratory symptom in Beijing, Oct-Dec, 2007] [220]
        Faceoff: Cuba vs. H1N1 influenza. [222]
        Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Dryingand Storage. [224]
        Genetic variation of Italian avian paramyxoviruses serotype 9. [226]
        Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-inducedpro-inflammatory cytokine and chemokine expression in human macrophages. [228]
        Dynamics and control of diseases in networks with community structure. [230]
        Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1illness during Spring-Summer 2009: four observational studies from Canada.[233]
        Does seasonal influenza vaccination increase the risk of illness with the 2009A/H1N1 pandemic virus? [236]
        Economic appraisal of Ontario's Universal Influenza Immunization Program: acost-utility analysis. [239]
        Spatial and temporal association of outbreaks of H5N1 influenza virus infectionin wild birds with the 0 degrees C isotherm. [242]
        Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled,randomized, double-blind crossover study. [245]
        Utility of Influenza Vaccination for Oncology Patients. [247]
        Herc5 Attenuates Influenza A Virus by Catalyzing ISGylation of Viral NS1Protein. [249]
        Detection of the rapid emergence of the H275Y mutation associated withoseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.[251]
        Computational study of drug binding to the membrane-bound tetrameric M2 peptidebundle from influenza A virus. [253]
        Perception of epidemic's related anxiety in the General French Population: across-sectional study in the Rhone-Alpes region. [255]
        Metabolic engineering for the production of shikimic acid in an evolvedEscherichia coli strain lacking the phosphoenolpyruvate: carbohydratephosphotransferase system. [257]
        FLU, an amino acid substitution model for influenza proteins. [259]
        Diagnostic accuracy of bedside antigen tests to correctly diagnose newInfluenza A/H1N1v Infection. [261]
        [Influence of novel influenza pandemic in 2009 on mental state of workers atlocal public hospital: an investigation using questionnaire] [263]
        Inhibition of H5N1 highly pathogenic influenza virus by suppressing a specificsialyltransferase. [265]
        Three amino acid changes in PB1-F2 of highly pathogenic H5N1 avian influenzavirus affect pathogenicity in mallard ducks. [267]
        Searching PubMed during a pandemic. [269]
        Lymphocyte to monocyte ratio as a screening tool for influenza. [272]
        A cross-sectional survey of influenza A infection and management practices insmall rural backyard poultry flocks in New Zealand. [275]
        A cross-sectional survey of biosecurity practices on Thoroughbred stud farms inNew Zealand. [277]
        Quantifying the contribution of leading causes of death to mortality declineamong older people in England, 1991-2005. [279]
        Influenza virus activates inflammasomes via its intracellular M2 ion channel.[281]
        Structures of influenza A proteins and insights into antiviral drug targets.[283]
        [Mathematical Modeling of the Novel Influenza A (H1N1) Virus and Evaluation ofthe Epidemic Response Strategies in the Republic of Korea.] [285]
        [The evaluation of policies on 2009 influenza pandemic in Korea.] [287]
        [National Level Response to Pandemic (H1N1) 2009.] [289]
        Pathology and Viral Antigen Distribution of Lethal Pneumonia in Domestic CatsDue to Pandemic (H1N1) 2009 Influenza A Virus. [291]
        Variability in Pathobiology of South Korean H5N1 High-Pathogenicity AvianInfluenza Virus Infection for 5 Species of Migratory Waterfowl. [293]
        Early host responses to avian influenza A virus are prolonged and enhanced attranscriptional level depending on maturation of the immune system. [295]
        Generation and characterization of a fusion protein of single-chain fragmentvariable antibody against hemagglutinin antigen of avian influenza virus andtruncated protamine. [297]
        Echinacea purpurea aerial extract alters course of influenza infection in mice.[299]
        Optimal control for pandemic influenza: The role of limited antiviral treatmentand isolation. [301]
        Detection of pandemic (H1N1) 2009 influenza virus by allele discrimination.[303]
        Fab MAbs Specific to HA of Influenza Virus with H5N1 Neutralizing ActivitySelected from Immunized Chicken Phage Library. [305]
        Where does amantadine bind to the influenza virus M2 proton channel? [307]
        [A(H1N1) influenza surveillance in the french armed forces: Adapting thesurveillance systems to the pandemic setting.] [309]
        Challenge and polymorphism analysis of the novel A (H1N1) influenza virus tonormal animals. [311]
        Visual Detection of Pandemic Influenza A H1N1 Virus 2009 by ReverseTranscription Loop-Mediated Isothermal Amplification with Hydroxynaphthol BlueDye. [313]
        Click reaction synthesis of carbohydrate derivatives from ristocetin aglyconwith antibacterial and antiviral activity. [315]
        Central European Vaccination Advisory Group (CEVAG) guidance statement onrecommendations for 2009 pandemic influenza A(H1N1) vaccination. [317]
        Comparison of Adjuvant Efficacy of Chitosan and Aluminum Hydroxide forIntraperitoneally Administered Inactivated Influenza H5N1 Vaccine. [319]
        Mixed Infections of Pandemic H1N1 and Seasonal H3N2 Viruses in 1 Outbreak.[321]
        Modelling the Transmission Dynamics and Control of the Novel 2009 SwineInfluenza (H1N1) Pandemic. [323]
        Influenza A (H1N1) pneumonia in an immunossupressed patient after hearttransplantation. [325]
        [Evaluation of a rapid antigenic method in the diagnosis of pandemic influenzaA (H1N1) virus in the pediatric population.] [327]
        Improving emergency preparedness capability of rural public health personnel inChina. [329]
        Immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1,NIBRG-14) vaccine administered by intramuscular or subcutaneous injection.[331]
        Viral Shedding and Clinical Illness in Naturally Acquired Influenza VirusInfections. [333]
        Immunogenicity and Safety of Intradermal Influenza Vaccination in Healthy OlderAdults. [335]
        Invasive Group A Streptococcal Infection Concurrent with 2009 H1N1 Influenza.[337]
        Influenza vaccine coverage in age-related risk groups in Poland, 2004-2007.[339]
        Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenzaand seasonal influenza during the "PROTECT" phase of the pandemic response.[341]
        [Assessment of current disinfectants to create a reserve in case of avianinfluenza outbreak] [343]
        Monitoring of all-cause mortality in Belgium (Be-MOMO): a new and automatedsystem for the early detection and quantification of the mortality impact ofpublic health events. [345]
        Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)vvirus from recent human influenza viruses by real-time PCR. [347]
        Features of the new pandemic influenza A/H1N1/2009 virus: virology,epidemiology, clinical and public health aspects. [350]
        Occupational respiratory infections. [352]
        Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-AdjuvantedPrepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 Years: A PhaseII, Randomized, Open, Controlled Study. [354]
        Enhancement of Antiviral Activity of Collectin Trimers through Cross-Linkingand Mutagenesis of the Carbohydrate Recognition Domain. [356]
        Verification of Poultry Carcass Composting Research through Application duringActual Avian Influenza Outbreaks. [358]
        Frequent Detection of Pandemic (H1N1) 2009 Virus in Stools of HospitalizedPatients. [360]
        Targeting pandemic influenza: a primer on influenza antivirals and drugresistance. [362]
        Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans inviral evolution and vaccine design. [364]
        H1N1: can a pandemic cycle be broken? [366]
        Targeting Robo4-dependent slit signaling to survive the cytokine storm insepsis and influenza. [368]
        Pig in a china shop: a personal perspective of how pandemic (H1N1) 2009affected the work of intensive care units in NSW. [370]
        Lessons from the NSW laboratory response to pandemic (H1N1) 2009 influenza.[372]
        Pandemic (H1N1) 2009 influenza vaccine roll-out in NSW. [374]
        Responding to pandemic (H1N1) 2009 influenza in Aboriginal communities in NSWthrough collaboration between NSW Health and the Aboriginalcommunity-controlled health sector. [376]
        Reflections on public health surveillance of pandemic (H1N1) 2009 influenza inNSW. [378]
        An influenza prophylaxis clinic in a primary school: 24 hours from notificationto protection. [380]
        Isolation and quarantine during pandemic (H1N1) 2009 influenza in NSW: theoperational experience of public health units. [382]
        Pandemic (H1N1) 2009 influenza in NSW: an overview of the public healthresponse. [384]
        Immunogenicity of avian H5N1 influenza virus recombinant vaccines in cats.[386]
        Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus.[388]
        Analyses of the specificity of CD4 T cells during the primary immune responseto influenza virus reveals dramatic MHC-linked asymmetries in reactivity toindividual viral proteins. [390]
        New tests for an old foe: an update on influenza screening. [392]
        Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis)infected with highly pathogenic avian influenza A (H5N1) virus. [394]
        Viral fusion: how Flu induces dimples on liposomes. [396]
        Perception and acceptance of intradermal influenza vaccination: Patientreported outcomes from phase 3 clinical trials. [398]
        Immunogenicity, large scale safety and lot consistency of an intradermalinfluenza vaccine in adults aged 18-60 years: Randomized, controlled, phase IIItrial. [400]
        Influenza A infection triggers thrombotic thrombocytopenic purpura by producingthe anti-ADAMTS13 IgG inhibitor. [402]
        High Titers of Hemagglutination Inhibition Antibodies against 2009 H1N1Influenza Virus in Southern Iran. [404]
        Financial effects of the highly pathogenic avian influenza outbreaks on theTurkish broiler producers. [406]
        Quality of care among obese patients. [408]
        Should we "rescue" patients with 2009 influenza A(H1N1) and lung injury fromconventional mechanical ventilation? [410]
        Vaccines with MF59 adjuvant expand the antibody repertoire to target protectivesites of pandemic avian H5N1 influenza virus. [412]
        Seasonal influenza vaccine provides priming for A/H1N1 immunization. [414]
        Response network analysis of differential gene expression in human epitheliallung cells during avian influenza infections. [416]
        Molecular epidemiology and antigenic analyses of influenza A Viruses H3N2 inTaiwan. [418]
        Modeling the viral dynamics of influenza a virus infection. [420]
        Satisfying the need for rapid diagnosis of new variant influenza A H1N1. [422]
        Safety and immunogenicity of influenza A H1N1 vaccines. [424]
        2009 Pandemic H1N1 Influenza Virus Replicates in Human Lung Tissues. [426]
        Antibody Responses of Raccoons Naturally Exposed to Influenza A Virus. [428]
        Occurrence of Influenza A(H1N1)v Virus in Western Romania in Relationship toInternational Travel. [430]
        Multiple Introduction of Asian H5N1 Avian Influenza Virus in Croatia by WildBirds During 2005-2006 and Isolation of the Virus from Apparently HealthyBlack-Headed Gulls (Larus ridibundus). [432]
        Tongue swelling complicating management of a ventilated patient with acuterespiratory distress syndrome secondary to novel influenza A (H1N1). [434]
        [Contemporary threat of influenza virus infection] [436]
        Immunogenicity of three different influenza vaccines against homologous andheterologous strains in nursing home elderly residents. [438]
        Functional glycosylation of dystroglycan is crucial for thymocyte developmentin the mouse. [441]
        Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versusOseltamivir as Treatment for Children with Influenza Virus Infection. [444]
        Safety of Influenza Vaccine Administration in Egg-Allergic Patients. [446]
        [The diagnostic value of fluorescence quantitative PCR in screening ofinfluenza A virus.] [448]
        [Report of 2 cases of novel influenza A (H1N1) virus infection complicated withpneumonia and hypoxemia.] [450]
        [Clinical features of 127 cases of novel influenza A (H1N1) infection in FujianProvince.] [452]
        [Clinical experience of successful management of the first human case withsevere influenza A H1N1 virus infection in Guiyang city.] [454]
        [Clinical characteristics and analysis of imaging in patients with severeinfluenza A H1N1 virus infection.] [456]
        [Clinical experience in the treatment of a pregnant woman suffering frominfluenza A H1N1 virus infection associated with acute respiratory distresssyndrome.] [458]
        [Clinical analysis of 75 patients with severe influenza A H1N1 in QinghaiProvince.] [460]
        [The use of extracorporeal membrane oxygenation in sustaining pulmonaryfunction patients with influenza A H1N1.] [462]
        [Eighteen cases of 2009 influenza A H1N1 associated with respiratory failure inadults.] [464]
        [Treatment of critically ill influenza A H1N1 patients in plateau region.][466]
        [The lung protection strategy under the support of extracorporeal membraneoxygenation in patients suffering from influenza A H1N1.] [468]
        A universal long-term flu vaccine may not prevent severe epidemics. [470]
        Personal Choice or Evidence-Based Nursing Intervention: Nurses' Decision-Makingabout Influenza Vaccination. [472]
        A collaborative approach to meeting the psychosocial needs of children duringan influenza pandemic. [474]
        Examining the knowledge of and attitudes to pandemic influenza among generalpractice staff. [476]
        Use of phylogenetics in the molecular epidemiology and evolutionary studies ofviral infections. [478]
        Pandemic influenza: severity must be taken into account. [480]
        Quasispecies of the D225G Substitution in the Hemagglutinin of PandemicInfluenza A(H1N1) 2009 Virus from Patients with Severe Disease in Hong Kong,China. [482]
        Unexplained increased incidence of Legionnaires disease during the "HeraldWave" of the H1N1 influenza pandemic. [484]
        Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009influenza virus. [486]
        [Identification of a pandemic influenza virus A/H1N1 by real-time PCR] [488]
        [Influenza and acute respiratory viral infections. A role of a polyclinictherapist in timely diagnosis and treatment] [490]
        [Antiviral activity of sulfated polysaccharide from the brown algae Laminariajaponica against avian influenza A (H5N1) virus infection in the culturedcells] [492]
        Establish the habit: influenza vaccination for health care personnel. [494]
        Consultation with health care professionals and influenza immunization amongwomen in contact with young children. [496]
        Another Nightmare After Sars: Knowledge Perceptions of and OvercomingStrategies for H1N1 Influenza Among Chronic Renal Disease Patients in HongKong. [498]
        RESPIRATORY VIRUSES IN ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA. [500]
        Limited compatibility of polymerase subunit interactions in influenza A and Bviruses. [502]
        Pandemic H1N1 Influenza in the Pediatric Emergency Department: A ComparisonWith Previous Seasonal Influenza Outbreaks. [504]
        Impact of oseltamivir treatment on the incidence and course of acute otitismedia in children with influenza. [506]
        Characteristics of US public schools with reported cases of novel influenza A(H1N1). [508]
        Characterization of two low pathogenic avian influenza viruses isolated inHungary in 2007. [510]
        Increasing influenza vaccination rates: Where is the behaviour change theory?[512]
        Validation of a method for preparing influenza H5N1 simulated samples. [514]
        Influenza virus infection in multinucleated skeletal myofibers. [516]
        Characterization of the interaction of influenza virus NS1 with Akt. [518]
        Etiology of bronchiolitis in a hospitalized pediatric population: Prospectivemulticenter study. [520]
        [Frequency of adverse reactions after influenza vaccination in health carepersonnel of a university hospital in Spain.] [522]
        Development of a multiplex real-time RT-PCR assay for detection of influenza A,influenza B, RSV and typing of the 2009-H1N1 influenza virus. [524]
        A protein chip designed to differentiate visually antibodies in chickens whichwere infected by four different viruses. [526]
        The non-structural (NS1) protein of influenza A virus associates with p53 andinhibits p53-mediated transcriptional activity and apoptosis. [528]
        [Review on the etiological property of the swine influenza virus] [530]
        [Laboratory confirmation of the first influenza A (H1N1) imported case inMainland China] [532]
        [Establishment of a method for rapid detection of the nucleic acid of the novelA (H1N1) influenza virus] [534]
        Evaluation of the efficacy of a specific hyperimmune serum in experimentalinfluenza infection in mice. [536]
        Deaths: leading causes for 2005. [537]
        An anti-influenza component of the bark of Alnus japonica. [539]
        Total synthesis of (+)-stachyflin: a potential anti-influenza A virus agent.[541]
        Estimating the disease burden of pandemic (H1N1) 2009 virus infection in HunterNew England, Northern New South Wales, Australia, 2009. [543]
        Contribution of company affiliation and social contacts to risk estimates ofbetween-farm transmission of avian influenza. [546]
        Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccinationcoverage - United States, October 2009-January 2010. [549]
        Interim results: influenza A (H1N1) 2009 monovalent and seasonal influenzavaccination coverage among health-care personnel - United States, August2009-January 2010. [551]
        [Impact on the population of media campaigns on the influenza H1N1A pandemic.Incidence on the act of shaking hands on saying goodbye, in a rural healthcentre.] [553]
        A novel mitogen fusion protein against CD40(+) cells with potent vaccineadjuvant properties. [555]
        Accuracy of online health information about controlling childhood fever duringthe H1N1 influenza pandemic. [557]
        Non-invasive ventilation in acute respiratory failure related to 2009 pandemicInfluenza A/H1N1 virus infection. [559]
        I'm interested in expert panflu damage estimates
        my current links: http://bit.ly/hFI7H ILI-charts: http://bit.ly/CcRgT

        Comment


        • #19
          Research Articles Abstracts - April 23 2010 Issue

          [Source: US National Library of Medicine, (LINK). Edited.]

          Research Articles Abstracts - April 23 2010 Issue

          1. Mayor S.
            • Department of Health agrees deal with GSK to cancel part of swine flu vaccine order.
            • BMJ. 2010;340:c1946.
            • PubMed
          2. Watson R.
            • WHO is accused of "crying wolf" over swine flu pandemic.
            • BMJ. 2010;340:c1904.
            • PubMed
          3. Kim SH, Samal S.
            • Inhibition of Host Innate Immune Responses and Pathogenicity of Recombinant Newcastle Disease Viruses Expressing NS1 Genes of Influenza A Viruses.
            • J Gen Virol. 2010.
            • PubMed
            • Abstract available
          4. Dimenna L, Latimer B, Parzych E, Haut LH, et al.
            • Augmentation of Primary Influenza A Virus-Specific CD8+ T Cell Responses in Aged Mice through Blockade of an Immunoinhibitory Pathway.
            • J Immunol. 2010.
            • PubMed
            • Abstract available
          5. Campbell AP, Chien JW, Kuypers J, Englund JA, et al.
            • Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.
            • J Infect Dis. 2010;201:1404-13.
            • PubMed
            • Abstract available
          6. Lynfield R.
            • Lessons from Queens.
            • J Infect Dis. 2010;201:973-5.
            • PubMed
          7. Miao H, Hollenbaugh JA, Zand MS, Holden-Wiltse J, et al.
            • Quantifying the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected by Influenza A Virus.
            • J Virol. 2010.
            • PubMed
            • Abstract available
          8. Soubies SM, Volmer C, Croville G, Loupias J, et al.
            • Species-specific Contribution of the Four C-terminal Amino Acids of Influenza A NS1 Protein to Virulence.
            • J Virol. 2010.
            • PubMed
            • Abstract available
          9. Lin YP, Gregory V, Collins P, Kloess J, et al.
            • Neuraminidase Receptor Binding Variants of Human Influenza A(H3N2) Viruses due to Substitution of Aspartic acid 151 in the Catalytic Site - Role in Virus Attachment?
            • J Virol. 2010.
            • PubMed
            • Abstract available
          10. Tu W, Mao H, Zheng J, Liu Y, et al.
            • Cytotoxic T Lymphocytes Established by Seasonal Human Influenza Cross-react against 2009 Pandemic H1N1 Influenza Virus.
            • J Virol. 2010.
            • PubMed
            • Abstract available
          11. Siston AM, Rasmussen SA, Honein MA, Fry AM, et al.
            • Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.
            • JAMA. 2010;303:1517-25.
            • PubMed
            • Abstract available
          12. Huang WT, Chuang JH, Kuo SH.
            • Monitoring the safety of pandemic H1N1 vaccine.
            • Lancet. 2010;375:1164.
            • PubMed
          13. Destefano F, Tokars J.
            • H1N1 vaccine safety monitoring: beyond background rates.
            • Lancet. 2009.
            • PubMed
          14. # ...
            • Update: influenza activity - United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine.
            • MMWR Morb Mortal Wkly Rep. 2010;59:423-30.
            • PubMed
            • Abstract available
          15. Liljebjelke KA, Petkov DI, Kapczynski DR.
            • Mucosal vaccination with a codon-optimized hemagglutinin gene expressed by attenuated Salmonella elicits a protective immune response in chickens against highly pathogenic avian influenza.
            • Vaccine. 2010.
            • PubMed
            • Abstract available
          16. Prieto-Lara E, Mendez AL.
            • Safety and immunogenicity of prepandemic H5N1 influenza vaccines: A systematic review of the literature.
            • Vaccine. 2010.
            • PubMed
            • Abstract available
          17. Chen Z, Zhou H, Jin H.
            • The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.
            • Vaccine. 2010.
            • PubMed
            • Abstract available
          18. Stephenson I, Hayden F, Osterhaus A, Howard W, et al.
            • Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009.
            • Vaccine. 2010.
            • PubMed
            • Abstract available
          19. Song JY, Cheong HJ, Hwang IS, Choi WS, et al.
            • Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence.
            • Vaccine. 2010.
            • PubMed
            • Abstract available
          20. Abed Y, Simon P, Boivin G.
            • Prophylactic Activity of Intramuscular Peramivir in Mice Infected with a Recombinant Influenza A/WSN/33 (H1N1) Virus Containing the H274Y Neuraminidase Mutation.
            • Antimicrob Agents Chemother. 2010.
            • PubMed
            • Abstract available

          -
          ------

          Comment


          • #20
            Research Articles Abstracts - April 30, 2010 Issue

            [Source: US National Library of Medicine, (LINK). Edited.]

            Research Articles Abstracts - April 30, 2010 Issue


            1. Ison MG, de Jong MD, Gilligan KJ, Higgs ES, et al.
              • End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life-Threatening Disease.
              • J Infect Dis. 2010.
              • PubMed
              • Abstract available
            2. Langley JM, Frenette L, Ferguson L, Riff D, et al.
              • Safety and Cross-Reactive Immunogenicity of Candidate AS03-Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults.
              • J Infect Dis. 2010.
              • PubMed
              • Abstract available
            3. Steinhoff MC, Omer SB, Roy E, Arifeen SE, et al.
              • Influenza immunization in pregnancy -- antibody responses in mothers and infants.
              • N Engl J Med. 2010;362:1644-6.
              • PubMed
            4. Valleron AJ, Cori A, Valtat S, Meurisse S, et al.
              • Transmissibility and geographic spread of the 1889 influenza pandemic.
              • Proc Natl Acad Sci U S A. 2010.
              • PubMed
              • Abstract available
            5. Brown KF, Kroll JS, Hudson MJ, Ramsay M, et al.
              • Omission bias and vaccine rejection by parents of healthy children: Implications for the influenza A/H1N1 vaccination programme.
              • Vaccine. 2010.
              • PubMed
              • Abstract available
            6. Chuaychoo B, Wongsurakiat P, Nana A, Kositanont U, et al.
              • The immunogenicity of intradermal influenza vaccination in COPD patients.
              • Vaccine. 2010.
              • PubMed
              • Abstract available
            7. Flasterstein OE, Samira S, Rochlin E, Balasingam S, et al.
              • Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.
              • Vaccine. 2010.
              • PubMed
              • Abstract available
            8. Rossi GA, Silvestri M, Lanari M.
              • Should the American Academy of Pediatrics respiratory syncytial virus guidelines be modified?
              • Pediatrics. 2010;125:e1021.
              • PubMed

            -
            ------

            Comment


            • #21
              Research Articles Abstract - May 10 2010 Issue

              [Source: US National Library of Medicine (LINK). Edited.]

              Research Articles Abstract - May 10 2010 Issue


              1. Campbell AP, Jacob ST, Kuypers J, Wald A, et al.
                • Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: Detection of extrapulmonary H1N1 RNA and use of intravenous peramivir.
                • Ann Intern Med. 2010;152:619-20.
                • PubMed
              2. Lee N, Chan PK, Lam WY, Szeto CC, et al.
                • Co-infection with pandemic H1N1 and seasonal H3N2 influenza viruses.
                • Ann Intern Med. 2010;152:618-9.
                • PubMed
              3. Sharshov K, Romanovskaya A, Uzhachenko R, Durymanov A, et al.
                • Genetic and biological characterization of avian influenza H5N1 viruses isolated from wild birds and poultry in Western Siberia.
                • Arch Virol. 2010.
                • PubMed
                • Abstract available
              4. Randall TD.
                • Pulmonary dendritic cells: thinking globally, acting locally.
                • J Exp Med. 2010;207:451-4.
                • PubMed
                • Abstract available
              5. Wu W, Booth JL, Duggan ES, Patel KB, et al.
                • Human lung innate immune cytokine response to adenovirus type 7.
                • J Gen Virol. 2010;91.
                • PubMed
                • Abstract available
              6. Herd KA, Nelson M, Mahalingam S, Tindle RW, et al.
                • Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus.
                • J Gen Virol. 2010;91.
                • PubMed
                • Abstract available
              7. Cornberg M, Clute SC, Watkin LB, Saccoccio FM, et al.
                • CD8 T Cell Cross-Reactivity Networks Mediate Heterologous Immunity in Human EBV and Murine Vaccinia Virus Infections.
                • J Immunol. 2010.
                • PubMed
                • Abstract available
              8. Erden I, Erden EC, Ozhan H, Basar C, et al.
                • Echocardiographic manifestations of pandemic 2009 (h1n1) influenza a virus infection.
                • J Infect. 2010.
                • PubMed
                • Abstract available
              9. Li R, Lim A, Phoon MC, Narasaraju T, et al.
                • Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm.
                • J Virol. 2010.
                • PubMed
                • Abstract available
              10. Murcia PR, Baillie GJ, Daly J, Elton D, et al.
                • The intra- and inter-host evolutionary dynamics of equine influenza virus.
                • J Virol. 2010.
                • PubMed
                • Abstract available
              11. Hale BG, Steel J, Medina RA, Manicassamy B, et al.
                • Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein.
                • J Virol. 2010.
                • PubMed
                • Abstract available
              12. Harker JA, Lee DC, Yamaguchi Y, Wang B, et al.
                • Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection.
                • J Virol. 2010;84:5294-302.
                • PubMed
                • Abstract available
              13. Shabat MB, Meir R, Haddas R, Lapin E, et al.
                • Development of a Real-Time TaqMan RT-PCR Assay for the Detection of H9N2 Avian Influenza Viruses.
                • J Virol Methods. 2010.
                • PubMed
                • Abstract available
              14. Ducatez MF, Sonnberg S, Hall RJ, Peacey M, et al.
                • Genotyping assay for the identification of 2009-2010 pandemic and seasonal H1N1 influenza virus reassortants.
                • J Virol Methods. 2010.
                • PubMed
                • Abstract available
              15. Vester D, Lagoda A, Hoffmann D, Seitz C, et al.
                • Real-time RT-qPCR assay for the analysis of human influenza A virus transcription and replication dynamics.
                • J Virol Methods. 2010.
                • PubMed
                • Abstract available
              16. ...
                • Licensure of a high-dose inactivated influenza vaccine for persons aged >or=65 years (Fluzone High-Dose) and guidance for use - United States, 2010.
                • MMWR Morb Mortal Wkly Rep. 2010;59:485-6.
                • PubMed
                • Abstract available
              17. ...
                • Interim results: state-specific seasonal influenza vaccination coverage - United States, August 2009-January 2010.
                • MMWR Morb Mortal Wkly Rep. 2010;59:477-84.
                • PubMed
                • Abstract available
              18. Brownstein JS, Freifeld CC, Chan EH, Keller M, et al.
                • Information technology and global surveillance of cases of 2009 H1N1 influenza.
                • N Engl J Med. 2010;362:1731-5.
                • PubMed
              19. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, et al.
                • Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection.
                • N Engl J Med. 2010;362:1708-19.
                • PubMed
              20. Grunwald C, Schulze K, Reichel A, Weiss VU, et al.
                • In situ assembly of macromolecular complexes triggered by light.
                • Proc Natl Acad Sci U S A. 2010;107:6146-51.
                • PubMed
                • Abstract available
              21. # Rehmani R, Memon JI.
                • Knowledge, attitudes and beliefs regarding influenza vaccination among healthcare workers in a Saudi hospital.
                • Vaccine. 2010.
                • PubMed
                • Abstract available
              22. Ansaldi F, Zancolli M, Paolo D, Montomoli E, et al.
                • Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.
                • Vaccine. 2010.
                • PubMed
                • Abstract available
              23. Baaten BJ, Clarke B, Strong P, Hou S, et al.
                • Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in the local pulmonary tissue.
                • Vaccine. 2010.
                • PubMed
                • Abstract available
              24. de Vries RP, de Vries E, Bosch BJ, de Groot RJ, et al.
                • The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity.
                • Virology. 2010.
                • PubMed
                • Abstract available

              -
              -----

              Comment


              • #22
                Research Articles Abstracts - May 16 2010 Issue

                [Source: US National Library of Medicine, (LINK). Edited.]

                Research Articles Abstracts - May 16 2010 Issue


                1. Chen Y, Luo W, Wu WL, Fang Z, et al.
                  • Humanized Antibodies with Broad-Spectrum Neutralization to Avian Influenza Virus H5N1.
                  • Antiviral Res. 2010.
                  • PubMed
                  • Abstract available
                2. Sweet M.
                  • Australia suspends seasonal flu vaccination of young children.
                  • BMJ. 2010;340:c2419.
                  • PubMed
                3. Mayor S.
                  • Hospital stays for young adults with flu shot up in England in 2009.
                  • BMJ. 2010;340:c2234.
                  • PubMed
                4. Fu YH, He JS, Wang XB, Zheng XX, et al.
                  • A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus.
                  • Biochem Biophys Res Commun. 2010;395:87-92.
                  • PubMed
                  • Abstract available
                5. Williams CJ, Buchholz U.
                  • Influence of household contacts on the effectiveness of face masks for preventing influenza in a healthcare setting: a comment on Cowling et al. (2010).
                  • Epidemiol Infect. 2010.
                  • PubMed
                6. Suzuki K, Okada H, Itoh T, Tada T, et al.
                  • Phenotypes influencing transmissibility of highly pathogenic avian influenza viruses in chickens.
                  • J Gen Virol. 2010.
                  • PubMed
                  • Abstract available
                7. Shanks GD, Mackenzie A, McLaughlin R, Waller M, et al.
                  • Mortality Risk Factors During the 1918-1919 Influenza Pandemic in the Australian Army.
                  • J Infect Dis. 2010.
                  • PubMed
                  • Abstract available
                8. Li Y, Lu X, Li J, Berube N, et al.
                  • Genetic engineered, biarsenical labelled influenza virus allows visualization of viral NS1 protein in living cells.
                  • J Virol. 2010.
                  • PubMed
                  • Abstract available
                9. Chan WH, Ng AK, Robb NC, Lam MK, et al.
                  • Functional analysis of influenza H5N1 nucleoprotein tail loop reveals amino acids that are crucial for oligomerization and ribonucleoprotein activities.
                  • J Virol. 2010.
                  • PubMed
                  • Abstract available
                10. Huang K, Bahl J, Fan XH, Vijaykrishna D, et al.
                  • Establishment of an H6N2 influenza virus lineage in domestic ducks in southern China.
                  • J Virol. 2010.
                  • PubMed
                  • Abstract available
                11. Qin M, Wang DY, Huang F, Nie K, et al.
                  • Detection of pandemic influenza A H1N1 virus by multiplex reverse transcription-PCR with a GeXP analyzer.
                  • J Virol Methods. 2010.
                  • PubMed
                  • Abstract available
                12. Furuse Y, Odagiri T, Okada T, Khandaker I, et al.
                  • Differentiation of human influenza A viruses including the pandemic subtype H1N1/2009 by conventional multiplex PCR.
                  • J Virol Methods. 2010.
                  • PubMed
                  • Abstract available
                13. Walley T, Davidson P.
                  • Research funding in a pandemic.
                  • Lancet. 2010;375:1063-5.
                  • PubMed
                14. Lau JT, Yeung NC, Choi KC, Cheng MY, et al.
                  • Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population.
                  • Vaccine. 2010.
                  • PubMed
                  • Abstract available
                15. Cohen SA, Ahmed S, Klassen AC, Agree EM, et al.
                  • Childhood Hib vaccination and pneumonia and influenza burden in US seniors.
                  • Vaccine. 2010.
                  • PubMed
                  • Abstract available
                16. Blank DL, Bodansky DM, Forbes A, Garde E, et al.
                  • Influenza vaccination of future healthcare workers: A cross-sectional study of uptake, knowledge and attitudes.
                  • Vaccine. 2010.
                  • PubMed
                  • Abstract available
                17. Wong LP, Sam IC.
                  • Factors influencing the uptake of 2009 H1N1 influenza vaccine in a multiethnic Asian population.
                  • Vaccine. 2010.
                  • PubMed
                  • Abstract available
                18. Walter EB, Rajagopal S, Zhu Y, Neuzil KM, et al.
                  • Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: Do children of all ages respond equally?
                  • Vaccine. 2010.
                  • PubMed
                  • Abstract available
                19. Hull HF.
                  • LAIV efficacy in military recruits.
                  • Vaccine. 2010;28:2066.
                  • PubMed
                20. Dinh A, Lawrence C, Salomon J, Descatha A, et al.
                  • Expected and unexpected adverse effects H1N1 vaccination for health care workers in a university hospital.
                  • Vaccine. 2009.
                  • PubMed
                21. Zhu H, Wang J, Wang P, Song W, et al.
                  • Substitution of lysine at 627 position in PB2 protein does not change virulence of the 2009 pandemic H1N1 virus in mice.
                  • Virology. 2010;401:1-5.
                  • PubMed
                  • Abstract available

                -
                ------

                Comment


                • #23
                  Research Articles Abstract - May 22 2010 Issue

                  [Source: US National Library of Medicine, (LINK). Edited.]

                  Research Articles Abstract - May 22 2010 Issue


                  1. Lai KY, Ng WY, Osburga Chan PK, Wong KF, et al.
                    • High-dose N-acetylcysteine therapy for novel H1N1 influenza pneumonia.
                    • Ann Intern Med. 2010;152:687-8.
                    • PubMed
                  2. Kumar P, Sood V, Vyas R, Gupta N, et al.
                    • Potent inhibition of influenza virus replication with novel siRNA-chimeric-ribozyme constructs.
                    • Antiviral Res. 2010.
                    • PubMed
                    • Abstract available
                  3. Acedo L, Diez-Domingo J, Morano JA, Villanueva RJ, et al.
                    • Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications.
                    • Epidemiol Infect. 2010;138:853-60.
                    • PubMed
                    • Abstract available
                  4. Cha W, Ma Y, Saif YM, Lee CW, et al.
                    • Development of microsphere-based multiplex branched DNA assay for the detection and differentiation of avian influenza virus.
                    • J Clin Microbiol. 2010.
                    • PubMed
                    • Abstract available
                  5. Ma W, Lager KM, Lekcharoensuk P, Ulery ES, et al.
                    • Viral reassortment and transmission after coinfection of pigs with classical H1N1 and triple reassortant H3N2 swine influenza viruses.
                    • J Gen Virol. 2010.
                    • PubMed
                    • Abstract available
                  6. Busquets N, Abad FX, Alba A, Dolz R, et al.
                    • Persistence of highly pathogenic avian influenza virus (H7N1) in infected chicken: feather as a suitable sample for diagnosis.
                    • J Gen Virol. 2010.
                    • PubMed
                    • Abstract available
                  7. Quan FS, Kim YC, Vunnava A, Yoo DG, et al.
                    • Intradermal vaccination with influenza VLPs using microneedles induces protection superior to intramuscular immunization.
                    • J Virol. 2010.
                    • PubMed
                    • Abstract available
                  8. Du N, Zhou J, Lin X, Zhang Y, et al.
                    • Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses.
                    • J Virol. 2010.
                    • PubMed
                    • Abstract available
                  9. Boon AC, Debeauchamp J, Krauss S, Rubrum A, et al.
                    • Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 influenza mouse model.
                    • J Virol. 2010.
                    • PubMed
                    • Abstract available
                  10. Steelfisher GK, Blendon RJ, Bekheit MM, Lubell K, et al.
                    • The Public's Response to the 2009 H1N1 Influenza Pandemic.
                    • N Engl J Med. 2010.
                    • PubMed
                  11. Partridge J, Kieny MP.
                    • Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets.
                    • Vaccine. 2010.
                    • PubMed
                    • Abstract available
                  12. Lee BY, Brown ST, Korch G, Cooley PC, et al.
                    • A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic.
                    • Vaccine. 2010.
                    • PubMed
                    • Abstract available
                  13. Yang CF, Belshe RB, Kemble G, Song E, et al.
                    • Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine.
                    • Vaccine. 2010.
                    • PubMed
                    • Abstract available
                  14. Wicker S, Rabenau HF.
                    • The reluctance of nurses to get vaccinated against influenza.
                    • Vaccine. 2010.
                    • PubMed
                  15. Virseda S, Restrepo MA, Arranz E, Magan-Tapia P, et al.
                    • Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital.
                    • Vaccine. 2010.
                    • PubMed
                    • Abstract available
                  16. Pushko P, Kort T, Nathan M, Pearce MB, et al.
                    • Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus.
                    • Vaccine. 2010.
                    • PubMed
                    • Abstract available
                  17. Eggert D, Thomas C, Spackman E, Pritchard N, et al.
                    • Characterization and efficacy determination of commercially available Central American H5N2 avian influenza vaccines for poultry.
                    • Vaccine. 2010.
                    • PubMed
                    • Abstract available

                  -
                  ------

                  Comment


                  • #24
                    Research Articles Abstracts - May 29 2010 Issue

                    [Source: US National Library of Medicine, (LINK). Edited.]

                    Research Articles Abstracts - May 29 2010 Issue


                    1. OOI PL, Lai FY, Low CL, Lin R, et al.
                      • Clinical and molecular evidence for transmission of novel influenza A(H1N1/2009)on a commercial airplane.
                      • Arch Intern Med. 2010;170:913-5.
                      • LINK
                    2. MILLER AC, Safi F, Hussain S, Subramanian RA, et al.
                      • Novel influenza A(H1N1) virus among gravid admissions.
                      • Arch Intern Med. 2010;170:868-73.
                      • ABSTRACT available
                    3. TANG JW, Tambyah PA, Lai FY, Lee HK, et al.
                      • Differing symptom patterns in early pandemic vs seasonal influenza infections.
                      • Arch Intern Med. 2010;170:861-7.
                      • ABSTRACT available
                    4. BAKER MG, Thornley CN, Mills C, Roberts S, et al.
                      • Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study.
                      • BMJ. 2010;340:c2424.
                      • ABSTRACT available
                    5. YANG P, Dongmei, Wang C, Tang C, et al.
                      • Characterization of a highly pathogenic avian influenza H5N1 virus isolated from an ostrich.
                      • Biochem Biophys Res Commun. 2010.
                      • ABSTRACT available
                    6. ANDRESEN DN, Kesson AM.
                      • High Sensitivity of a Rapid Immunochromatographic Test for the Detection of Influenza A Virus 2009 H1N1 on Nasopharyngeal Aspirates from Young Children.
                      • J Clin Microbiol. 2010.
                      • ABSTRACT available
                    7. HOSSAIN MJ, Perez S, Guo Z, Chen LM, et al.
                      • Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays.
                      • J Clin Microbiol. 2010.
                      • ABSTRACT available
                    8. LAI JC, Chan WW, Kien F, Nicholls JM, et al.
                      • Formation of virus-like particles from human cell lines exclusively expressing Influenza neuraminidase.
                      • J Gen Virol. 2010.
                      • ABSTRACT available
                    9. GUO H, Topham DJ.
                      • IL-22 production by pulmonary natural killer cells and the potential role of IL-22 during primary influenza infection.
                      • J Virol. 2010.
                      • ABSTRACT available
                    10. CHEN GL, Lamirande EW, Yang CF, Jin H, et al.
                      • EVALUATION OF REPLICATION AND CROSS-REACTIVE ANTIBODY RESPONSE OF H2 INFLUENZA SUBTYPE VIRUSES IN MICE AND FERRETS.
                      • J Virol. 2010.
                      • ABSTRACT available
                    11. DE LUCAS S, Peredo J, Marion RM, Sanchez C, et al.
                      • Human Staufen1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus multiplication.
                      • J Virol. 2010.
                      • ABSTRACT available
                    12. LANGLEY WA, Bradley KC, Li ZN, Smith ME, et al.
                      • Induction of neutralizing antibody responses to anthrax PA using influenza vectors: Implications for disparate immune system priming pathways.
                      • J Virol. 2010.
                      • ABSTRACT available
                    13. TATE MD, Pickett DL, van Rooijen N, Brooks AG, et al.
                      • The Critical Role of Airway Macrophages in Modulating Disease Severity During Influenza Virus Infection of Mice.
                      • J Virol. 2010.
                      • ABSTRACT available
                    14. CILLONIZ C, Pantin-Jackwood MJ, Ni C, Goodman AG, et al.
                      • Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection.
                      • J Virol. 2010.
                      • ABSTRACT available
                    15. CHAKRAVARTHY KV, Bonoiu AC, Davis WG, Ranjan P, et al.
                      • Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.
                      • Proc Natl Acad Sci U S A. 2010.
                      • ABSTRACT available
                    16. CALDER LJ, Wasilewski S, Berriman JA, Rosenthal PB, et al.
                      • Structural organization of a filamentous influenza A virus.
                      • Proc Natl Acad Sci U S A. 2010.
                      • ABSTRACT available
                    17. TAMURA SI.
                      • Studies on the usefulness of intranasal inactivated influenza vaccines.
                      • Vaccine. 2010.
                      • ABSTRACT available
                    18. PALMER LA, Rousculp MD, Johnston SS, Mahadevia PJ, et al.
                      • Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study.
                      • Vaccine. 2010.
                      • ABSTRACT available
                    19. MELIDOU A, Gioula G, Exindari M, Chatzidimitriou D, et al.
                      • Molecular and phylogenetic analysis of the haemagglutinin gene of pandemic influenza H1N1 2009 viruses associated with severe and fatal infections.
                      • Virus Res. 2010.
                      • ABSTRACT available
                    20. BROWN A, McSharry JJ, Weng Q, Driebe EM, et al.
                      • An In Vitro System for Modeling Influenza A Virus Resistance under Drug Pressure.
                      • Antimicrob Agents Chemother. 2010.
                      • ABSTRACT available

                    -
                    -----

                    Comment


                    • #25
                      Research Articles Abstracts - June 4 2010 Issue

                      [Source: US National Library of Medicine, (LINK). Edited.]

                      Research Articles Abstracts - June 4 2010 Issue

                      1. Waddington CS, Walker WT, Oeser C, Reiner A, et al.
                        • Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.
                        • BMJ. 2010;340:c2649.
                        • PubMed
                        • Abstract available
                      2. Higgins AD, Shaw CJ, Johnson JG, Navarro A, et al.
                        • A Monoclonal Antibody Kit for Identification of the Novel 2009 H1N1 Influenza A Virus.
                        • J Clin Microbiol. 2010.
                        • PubMed
                        • Abstract available
                      3. Robb N, Jackson D, Vreede F, Fodor E, et al.
                        • Splicing of Influenza A Virus NS1 mRNA is Independent of the Viral NS1 Protein.
                        • J Gen Virol. 2010.
                        • PubMed
                        • Abstract available
                      4. Shinya K, Makino A, Hatta M, Watanabe S, et al.
                        • A mutation in H5 haemagglutinin that conferred human receptor recognition is not maintained stably during duck passage.
                        • J Gen Virol. 2010;91.
                        • PubMed
                        • Abstract available
                      5. Stevens J, Chen LM, Carney PJ, Garten R, et al.
                        • Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      6. Manz B, Matrosovich M, Bovin N, Schwemmle M, et al.
                        • A polymorphism in the hemagglutinin of the human isolate of a highly pathogenic H5N1 influenza virus determines organ tropism in mice.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      7. Munster VJ, Schrauwen EJ, de Wit E, van den Brand JM, et al.
                        • Insertion of a multi basic cleavage motif into the hemagglutinin of a low pathogenic avian influenza H6N1 virus induces a highly pathogenic phenotype.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      8. Oh HL, Akerstrom S, Shen S, Bereczky S, et al.
                        • An antibody against a novel and conserved epitope in the HA1 subunit neutralizes numerous H5N1 influenza viruses.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      9. Seo YJ, Blake C, Alexander S, Hahm B, et al.
                        • Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cyto-pathogenicity.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      10. Gao Q, Lowen AC, Wang TT, Palese P, et al.
                        • A nine-segmented influenza A virus carrying H1 and H3 subtype hemagglutinins.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      11. Govorkova EA, Ilyushina NA, Marathe BM, McClaren JL, et al.
                        • Competitive Fitness of Oseltamivir-Sensitive and -Resistant Highly Pathogenic H5N1 Influenza Viruses in a Ferret Model.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      12. Bodewes R, Kreijtz JH, van Amerongen G, Geelhoed-Mieras MM, et al.
                        • A single immunization with CoVaccine HTTM-adjuvanted H5N1 influenza vaccine induces protective cellular and humoral immune responses in ferrets.
                        • J Virol. 2010.
                        • PubMed
                        • Abstract available
                      13. Berkley JA, Munywoki P, Ngama M, Kazungu S, et al.
                        • Viral etiology of severe pneumonia among Kenyan infants and children.
                        • JAMA. 2010;303:2051-7.
                        • PubMed
                        • Abstract available
                      14. ...
                        • Preliminary Results: Surveillance for Guillain-Barre Syndrome After Receipt of Influenza A (H1N1) 2009 Monovalent Vaccine --- United States, 2009--2010.
                        • MMWR Morb Mortal Wkly Rep. 2010;59:657-61.
                        • PubMed
                        • Abstract available
                      15. DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, et al.
                        • A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus.
                        • Proc Natl Acad Sci U S A. 2010;107:8800-5.
                        • PubMed
                        • Abstract available
                      16. Turner RB, Fuls JL, Rodgers ND.
                        • Effectiveness of hand sanitizers with and without organic acids for removal of rhinovirus from hands.
                        • Antimicrob Agents Chemother. 2010;54:1363-4.
                        • PubMed
                        • Abstract available

                      -
                      ------

                      Comment


                      • #26
                        Research Articles Abstracts - June 11 2010 Issue

                        [Source: US National Library of Medicine, (LINK). Edited.]

                        Research Articles Abstracts - June 11 2010 Issue

                        1. Monteerarat Y, Sakabe S, Ngamurulert S, Srichatraphimuk S, et al.
                          • Induction of TNF-alpha in human macrophages by avian and human influenza viruses.
                          • Arch Virol. 2010.
                          • PubMed
                          • Abstract available
                        2. Voeten JT, Kiseleva IV, Glansbeek HL, Basten SM, et al.
                          • Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
                          • Arch Virol. 2010.
                          • PubMed
                          • Abstract available
                        3. Martinez M, Perez AM, DE LA Torre A, Iglesias I, et al.
                          • Evaluating surveillance in wild birds by the application of risk assessment of avian influenza introduction into Spain.
                          • Epidemiol Infect. 2010.
                          • PubMed
                          • Abstract available
                        4. Moscona A, Porotto M, Palmer S, Tai C, et al.
                          • A Recombinant Sialidase Fusion Protein Effectively Inhibits Human Parainfluenza Viral Infection In Vitro and In Vivo.
                          • J Infect Dis. 2010.
                          • PubMed
                          • Abstract available
                        5. Fang Y, Rowe T, Leon AJ, Banner D, et al.
                          • Molecular Characterization of in vivo Adjuvant Activity in Influenza-Vaccinated Ferrets.
                          • J Virol. 2010.
                          • PubMed
                          • Abstract available
                        6. Kirby T.
                          • Jim Bishop: the Chief Medical Officer of Australia.
                          • Lancet. 2010;375:1517.
                          • PubMed
                        7. Hall CB.
                          • Respiratory syncytial virus in young children.
                          • Lancet. 2010;375:1500-2.
                          • PubMed
                        8. Nair H, Nokes DJ, Gessner BD, Dherani M, et al.
                          • Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.
                          • Lancet. 2010;375:1545-55.
                          • PubMed
                          • Abstract available
                        9. ...
                          • Deaths and Hospitalizations Related to 2009 Pandemic Influenza A (H1N1) --- Greece, May 2009--February 2010.
                          • MMWR Morb Mortal Wkly Rep. 2010;59:682-6.
                          • PubMed
                          • Abstract available
                        10. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, et al.
                          • Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus.
                          • Proc Natl Acad Sci U S A. 2010.
                          • PubMed
                          • Abstract available
                        11. Lorieau JL, Louis JM, Bax A.
                          • The complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid:water interface.
                          • Proc Natl Acad Sci U S A. 2010.
                          • PubMed
                          • Abstract available
                        12. Perez JT, Varble A, Sachidanandam R, Zlatev I, et al.
                          • Influenza A virus-generated small RNAs regulate the switch from transcription to replication.
                          • Proc Natl Acad Sci U S A. 2010.
                          • PubMed
                          • Abstract available
                        13. Kim JK, Kayali G, Walker D, Forrest HL, et al.
                          • Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry.
                          • Proc Natl Acad Sci U S A. 2010.
                          • PubMed
                          • Abstract available

                        -
                        -----

                        Comment


                        • #27
                          Research Articles Abstracts - June 18 2010 Issue

                          Research Articles Abstracts - June 18 2010 Issue

                          [Source: US National Library of Medicine, (LINK). Edited.]

                          Research Articles Abstracts - June 18 2010 Issue

                          1. Zarocostas J.
                            • Swine flu pandemic review panel seeks access to confidential documents between WHO and drug companies.
                            • BMJ. 2010;340:c2792.
                            • PubMed
                          2. Iglesias I, Perez AM, Sanchez-Vizcaino JM, Munoz MJ, et al.
                            • Reproductive ratio for the local spread of highly pathogenic avian influenza in wild bird populations of Europe, 2005-2008.
                            • Epidemiol Infect. 2010.
                            • PubMed
                            • Abstract available
                          3. Ajelli M, Merler S, Pugliese A, Rizzo C, et al.
                            • Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy.
                            • Epidemiol Infect. 2010.
                            • PubMed
                            • Abstract available
                          4. Sakai-Tagawa Y, Ozawa M, Tamura D, Le QM, et al.
                            • Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses.
                            • J Clin Microbiol. 2010.
                            • PubMed
                            • Abstract available
                          5. Zhang ZY, Du LN, Chen X, Zhao Y, et al.
                            • Genetic variability of respiratory syncytial viruses (RSV) prevalent in Southwestern China from 2006 to 2009: emergence of subgroup B and A RSV as dominant strains.
                            • J Clin Microbiol. 2010;48:1201-7.
                            • PubMed
                            • Abstract available
                          6. Chen J, Huang S, Chen Z.
                            • Human cellular protein nucleoporin hNup98 interacts with influenza A virus NS2/NEP protein and over-expression of its GLFG repeat domain can inhibit virus propagation.
                            • J Gen Virol. 2010.
                            • PubMed
                            • Abstract available
                          7. Sun X, Tse LV, Ferguson AD, Whittaker GR, et al.
                            • Modifications to the hemagglutinin cleavage site control virulence of a neurotropic H1N1 influenza virus.
                            • J Virol. 2010.
                            • PubMed
                            • Abstract available
                          8. Song L, Liu H, Gao S, Jiang W, et al.
                            • Cellular MicroRNAs Inhibit Replication of the H1N1 Influenza A Virus in Infected Cells.
                            • J Virol. 2010.
                            • PubMed
                            • Abstract available
                          9. Li Y, Shi J, Zhong G, Deng G, et al.
                            • Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry and humans in China from 2004 to 2009.
                            • J Virol. 2010.
                            • PubMed
                            • Abstract available
                          10. Graef KM, Vreede FT, Lau YF, McCall AW, et al.
                            • The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with MAVS and inhibiting IFN-{beta} expression.
                            • J Virol. 2010.
                            • PubMed
                            • Abstract available
                          11. Lau YF, Tang LH, McCall AW, Ooi EE, et al.
                            • An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza vaccine with antigen-sparing effect in mice.
                            • J Virol. 2010.
                            • PubMed
                            • Abstract available
                          12. Small PA Jr, Morris JG Jr.
                            • Influenza vaccination of children and infection rates in the community.
                            • JAMA. 2010;303:2355-6.
                            • PubMed
                          13. Goldkind SF, Sahin L, Gallauresi B.
                            • Enrolling pregnant women in research--lessons from the H1N1 influenza pandemic.
                            • N Engl J Med. 2010;362:2241-3.
                            • PubMed
                          14. Scull MA, Rice CM.
                            • A big role for small RNAs in influenza virus replication.
                            • Proc Natl Acad Sci U S A. 2010.
                            • PubMed
                          15. van der Weijden CP, Bredenoord AL, van Delden JJ.
                            • The duty to treat in the context of an influenza pandemic.
                            • Vaccine. 2010.
                            • PubMed
                            • Abstract available
                          16. Sy LS, Liu IL, Solano Z, Cheetham TC, et al.
                            • Accuracy of influenza vaccination status in a computer-based immunization tracking system of a managed care organization.
                            • Vaccine. 2010.
                            • PubMed
                            • Abstract available
                          17. Girard MP, Tam JS, Assossou OM, Kieny MP, et al.
                            • The 2009 A (H1N1) influenza virus pandemic: A review.
                            • Vaccine. 2010.
                            • PubMed
                            • Abstract available
                          18. Lau JT, Cai Y, Tsui HY, Choi KC, et al.
                            • Prevalence of influenza vaccination and associated factors among pregnant women in Hong Kong.
                            • Vaccine. 2010.
                            • PubMed
                            • Abstract available
                          19. Orellano PW, Reynoso JI, Carlino O, Uez O, et al.
                            • Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina.
                            • Vaccine. 2010.
                            • PubMed
                            • Abstract available
                          20. Pu J, Wang J, Zhang Y, Fu G, et al.
                            • Synergism of co-mutation of two amino acid residues in NS1 protein increases the pathogenicity of influenza virus in mice.
                            • Virus Res. 2010.
                            • PubMed
                            • Abstract available

                          -
                          -----

                          Comment


                          • #28
                            Research Articles Abstracts - June 25 2010 Issue

                            [Source: US National Library of Medicine, (LINK). Edited.]

                            Research Articles Abstracts - June 25 2010 Issue


                            1. Qi T, Guo W, Huang WQ, Li HM, et al.
                              • Genetic evolution of equine influenza viruses isolated in China.
                              • Arch Virol. 2010.
                              • PubMed
                              • Abstract available
                            2. Moynihan R.
                              • Australian government says healthy under 5s should not be given seasonal flu jab.
                              • BMJ. 2010;340:c2991.
                              • PubMed
                            3. O'Dowd A.
                              • Council of Europe condemns "unjustified scare" over swine flu.
                              • BMJ. 2010;340:c3033.
                              • PubMed
                            4. Godlee F.
                              • Conflicts of interest and pandemic flu.
                              • BMJ. 2010;340:c2947.
                              • PubMed
                            5. Cohen D, Carter P.
                              • Conflicts of interest. WHO and the pandemic flu "conspiracies".
                              • BMJ. 2010;340:c2912.
                              • PubMed
                            6. Doyle TJ, Hopkins RS.
                              • Low secondary transmission of 2009 pandemic influenza A (H1N1) in households following an outbreak at a summer camp: relationship to timing of exposure.
                              • Epidemiol Infect. 2010.
                              • PubMed
                              • Abstract available
                            7. Grantham ML, Stewart SM, Lalime EN, Pekosz A, et al.
                              • Tyrosines in the influenza A virus M2 protein cytoplasmic tail are critical for the production of infectious virus particles.
                              • J Virol. 2010.
                              • PubMed
                              • Abstract available
                            8. Fislova T, Thomas B, Graef KM, Fodor E, et al.
                              • Association of the influenza virus RNA polymerase subunit PB2 with the host chaperonin CCT.
                              • J Virol. 2010.
                              • PubMed
                              • Abstract available
                            9. Uyeki TM.
                              • 2009 H1N1 virus transmission and outbreaks.
                              • N Engl J Med. 2010;362:2221-3.
                              • PubMed
                            10. Cowling BJ, Chan KH, Fang VJ, Lau LL, et al.
                              • Comparative epidemiology of pandemic and seasonal influenza A in households.
                              • N Engl J Med. 2010;362:2175-84.
                              • PubMed
                              • Abstract available
                            11. Lee VJ, Yap J, Cook AR, Chen MI, et al.
                              • Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks.
                              • N Engl J Med. 2010;362:2166-74.
                              • PubMed
                              • Abstract available
                            12. Stittelaar KJ, Lacombe V, van Lavieren R, van Amerongen G, et al.
                              • Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine.
                              • Vaccine. 2010.
                              • PubMed
                              • Abstract available
                            13. Kanai Y, Boonsathorn N, Chittaganpitch M, Bai G, et al.
                              • The impact of antigenic drift of influenza A virus on human herd immunity: Sero-epidemiological study of H1N1 in healthy Thai population in 2009.
                              • Vaccine. 2010.
                              • PubMed
                              • Abstract available
                            14. Singh S, Toro H, Tang DC, Briles WE, et al.
                              • Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes.
                              • Virology. 2010.
                              • PubMed
                              • Abstract available

                            -
                            ------

                            Comment


                            • #29
                              Research Articles Abstracts - July 2 2010 Issue

                              Research Articles Abstracts - July 2 2010 Issue

                              [Source: US National Library of Medicine, (LINK). Edited.]

                              Research Articles Abstracts - July 2 2010 Issue


                              1. Palmer SM, Limaye AP, Banks M, Gallup D, et al.
                                • Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial.
                                • Ann Intern Med. 2010;152:761-9.
                                • PubMed
                                • Abstract available
                              2. Pillai SP, Pantin-Jackwood M, Suarez DL, Saif YM, et al.
                                • Pathobiological characterization of low-pathogenicity H5 avian influenza viruses of diverse origins in chickens, ducks and turkeys.
                                • Arch Virol. 2010.
                                • PubMed
                                • Abstract available
                              3. Abraham T.
                                • The price of poor pandemic communication.
                                • BMJ. 2010;340:c2952.
                                • PubMed
                              4. Bonneux L, Van Damme W.
                                • Preventing iatrogenic pandemics of panic. Do it in a NICE way.
                                • BMJ. 2010;340:c3065.
                                • PubMed
                              5. Collignon P, Doshi P, Jefferson T.
                                • Child influenza vaccination. Ramifications of adverse events in children in Australia.
                                • BMJ. 2010;340:c2994.
                                • PubMed
                              6. Le QM, Ito M, Muramoto Y, Hoang PV, et al.
                                • Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans from 2003 to 2008 in Northern Vietnam.
                                • J Gen Virol. 2010.
                                • PubMed
                                • Abstract available
                              7. Skountzou I, Koutsonanos DG, Kim JH, Powers R, et al.
                                • Immunity to Pre-1950 H1N1 Influenza Viruses Confers Cross-Protection against the Pandemic Swine-Origin 2009 A (H1N1) Influenza Virus.
                                • J Immunol. 2010.
                                • PubMed
                                • Abstract available
                              8. Coomes SM, Wilke CA, Moore TA, Moore BB, et al.
                                • Induction of TGF-{beta}1, Not Regulatory T Cells, Impairs Antiviral Immunity in the Lung following Bone Marrow Transplant.
                                • J Immunol. 2010.
                                • PubMed
                                • Abstract available
                              9. Wu B, Wang C, Dong G, Guo Y, et al.
                                • New Evidence Suggests Southern China as a Common Source of Multiple Clusters of Highly Pathogenic H5N1 Avian Influenza Virus.
                                • J Infect Dis. 2010.
                                • PubMed
                                • Abstract available
                              10. Dudek SE, Luig C, Pauli EK, Schubert U, et al.
                                • The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state.
                                • J Virol. 2010.
                                • PubMed
                                • Abstract available
                              11. Crepin T, Dias A, Palencia A, Swale C, et al.
                                • Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunit.
                                • J Virol. 2010.
                                • PubMed
                                • Abstract available
                              12. Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, et al.
                                • Adaptation of pandemic H1N1 influenza viruses in mice.
                                • J Virol. 2010.
                                • PubMed
                                • Abstract available
                              13. Teijaro JR, Verhoeven D, Page CA, Turner D, et al.
                                • Memory CD4 T cells Direct Protective Responses to Influenza Virus in the Lung through Helper-independent Mechanisms.
                                • J Virol. 2010.
                                • PubMed
                                • Abstract available
                              14. Kaminski A, Poyry TA, Skene PJ, Jackson RJ, et al.
                                • Mechanism of initiation site selection promoted by the human rhinovirus 2 internal ribosome entry site.
                                • J Virol. 2010;84:6578-89.
                                • PubMed
                                • Abstract available
                              15. Gilman SL.
                                • Moral panic and pandemics.
                                • Lancet. 2010;375:1866-7.
                                • PubMed
                              16. Hens N, Van Ranst M, Aerts M, Robesyn E, et al.
                                • Estimating the effective reproduction number for pandemic influenza from notification data made publicly available in real time: A multi-country analysis for influenza A/H1N1v 2009.
                                • Vaccine. 2010.
                                • PubMed
                                • Abstract available
                              17. Looijmans-van den Akker I, van Delden JJ, Verheij TJ, van der Sande MA, et al.
                                • Effects of a multi-faceted program to increase influenza vaccine uptake among health care workers in nursing homes: A cluster randomised controlled trial.
                                • Vaccine. 2010.
                                • PubMed
                                • Abstract available
                              18. Fairbrother G, Cassedy A, Ortega-Sanchez IR, Szilagyi PG, et al.
                                • High costs of influenza: Direct medical costs of influenza disease in young children.
                                • Vaccine. 2010.
                                • PubMed
                                • Abstract available
                              19. Chen Y, Zhong G, Wang G, Deng G, et al.
                                • Dogs are highly susceptible to H5N1 avian influenza virus.
                                • Virology. 2010.
                                • PubMed
                                • Abstract available
                              20. Song JM, Hossain J, Yoo DG, Lipatov AS, et al.
                                • Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles.
                                • Virology. 2010.
                                • PubMed
                                • Abstract available
                              21. Nguyen HT, Sheu TG, Mishin VP, Klimov AI, et al.
                                • Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.
                                • Antimicrob Agents Chemother. 2010.
                                • PubMed
                                • Abstract available

                              -
                              ------

                              Comment


                              • #30
                                Research Articles Abstracts - July 9 2010 Issue

                                [Source: US National Library of Medicine, (LINK). Edited.]

                                Research Articles Abstracts - July 9 2010 Issue

                                1. Hurt AC, Lowther S, Middleton D, Barr IG, et al.
                                  • Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
                                  • Antiviral Res. 2010.
                                  • PubMed
                                  • Abstract available
                                2. Laurell AC, Herrera JR.
                                  • WHO and pandemic flu. What happened in Mexico.
                                  • BMJ. 2010;340:c3465.
                                  • PubMed
                                3. Kon P.
                                  • WHO and pandemic flu. GlaxoSmithKline UK responds.
                                  • BMJ. 2010;340:c3464.
                                  • PubMed
                                4. Chan M.
                                  • WHO Director-General replies to the BMJ.
                                  • BMJ. 2010;340:c3463.
                                  • PubMed
                                5. Jefferson T, Doshi P.
                                  • WHO and pandemic flu. Time for change, WHO.
                                  • BMJ. 2010;340:c3461.
                                  • PubMed
                                6. Law R.
                                  • WHO and pandemic flu. There was also no new subtype.
                                  • BMJ. 2010;340:c3460.
                                  • PubMed
                                7. Doshi P, Jefferson T.
                                  • WHO and pandemic flu. Another question for GSK.
                                  • BMJ. 2010;340:c3455.
                                  • PubMed
                                8. McLean E, Pebody RG, Campbell C, Chamberland M, et al.
                                  • Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases.
                                  • Epidemiol Infect. 2010.
                                  • PubMed
                                  • Abstract available
                                9. Maltezou HC, Dedoukou X, Patrinos S, Maragos A, et al.
                                  • Determinants of Intention to get vaccinated against Novel (Pandemic) Influenza A H1N1 among Health-Care Workers in a Nationwide Survey.
                                  • J Infect. 2010.
                                  • PubMed
                                  • Abstract available
                                10. Lalayianni C.
                                  • Outbreak of novel influenza a (h1n1) in an adult haematology department and haematopoietic cell transplantation unit: Clinical presentation and outcome.
                                  • J Infect. 2010.
                                  • PubMed
                                11. Chowell G, Viboud C, Simonsen L, Miller MA, et al.
                                  • Mortality Patterns Associated with the 1918 Influenza Pandemic in Mexico: Evidence for a Spring Herald Wave and Lack of Preexisting Immunity in Older Populations.
                                  • J Infect Dis. 2010.
                                  • PubMed
                                  • Abstract available
                                12. Acosta EP, Jester P, Gal P, Wimmer J, et al.
                                  • Oseltamivir Dosing for Influenza Infection in Premature Neonates.
                                  • J Infect Dis. 2010.
                                  • PubMed
                                  • Abstract available
                                13. Esposito DH, Gardner TJ, Schneider E, Stockman LJ, et al.
                                  • Outbreak of pneumonia associated with emergent human adenovirus serotype 14--Southeast Alaska, 2008.
                                  • J Infect Dis. 2010;202:214-22.
                                  • PubMed
                                  • Abstract available
                                14. Chidlow GR, Harnett GB, Williams SH, Tempone SS, et al.
                                  • The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay.
                                  • J Virol Methods. 2010.
                                  • PubMed
                                  • Abstract available
                                15. Chapman GB, Li M, Colby H, Yoon H, et al.
                                  • Opting in vs opting out of influenza vaccination.
                                  • JAMA. 2010;304:43-4.
                                  • PubMed
                                16. Song H, Wittman V, Byers A, Tapia T, et al.
                                  • In vitro stimulation of human influenza-specific CD8(+) T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                17. Torun SD, Torun F.
                                  • Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                18. Lin J, Somanathan S, Roy S, Calcedo R, et al.
                                  • Lung homing CTLs and their proliferation ability are important correlates of vaccine protection against influenza.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                19. Lu CY, Shao PL, Chang LY, Huang YC, et al.
                                  • Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                20. Oh CE, Lee J, Kang JH, Hong YJ, et al.
                                  • Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: A prospective, open-label, multi-center trial.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                21. Hara M, Tanaka K, Kase T, Maeda A, et al.
                                  • Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                22. Carmona A, Omenaca F, Tejedor JC, Merino JM, et al.
                                  • Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                23. Misplon JA, Lo CY, Gabbard JD, Tompkins SM, et al.
                                  • Genetic control of immune responses to influenza A matrix 2 protein (M2).
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                24. Keawcharoen J, Spronken MI, Vuong O, Bestebroer TM, et al.
                                  • Repository of Eurasian influenza A virus hemagglutinin and neuraminidase reverse genetics vectors and recombinant viruses.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                25. Kraigher A, Ucakar V.
                                  • Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season 2009/10.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                26. Bozzola E, Krzysztofiak A, Lancella L, Tozzi A, et al.
                                  • Risk factors of complicated H1N1 influenza in hospitalized Italian children.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                27. Riffault S, Meyer G, Deplanche M, Dubuquoy C, et al.
                                  • A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus.
                                  • Vaccine. 2010.
                                  • PubMed
                                  • Abstract available
                                28. Furuse Y, Shimabukuro K, Odagiri T, Sawayama R, et al.
                                  • Comparison of selection pressures on the HA gene of pandemic (2009) and seasonal human and swine influenza A H1 subtype viruses.
                                  • Virology. 2010.
                                  • PubMed
                                  • Abstract available

                                -
                                -----

                                Comment

                                Working...
                                X